Delivery Order SPE2DB22D2211-SPE2DB24FNCZ3
- Not listed
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of 100 units of the pharmaceutical drug Vyvanse (40 mg capsules). The total potential value of this order is $1,012.50, with a completion date of February 23, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,251,614 units of Vyvanse 10 mg capsules. The delivery order has a ceiling value of $12,387.82 and a period of performance through February 9, 2022. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used for this award. The delivery order is part of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,564,118,788 units of the pharmaceutical product Vyvanse 50 mg capsules. The total ceiling value of the contract is $10,020.09 with a performance period through April 1, 2024. This delivery order falls under a larger...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Vyvanse 10 mg capsules. The award has a potential value of $4,126.32 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Vyvanse 40 mg capsules, a brand name pharmaceutical product, with a ceiling value of $1,054.38 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of Vyvanse 40 mg capsules in 100-count packages, with a ceiling value of $2,704.83 and a period of performance through June 10, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 10 milligram Vyvanse capsules, a specialty medication, valued at $5,133.04 with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,787,389 units of 40 mg Vyvanse capsules. The contract has a potential value of $2,038.25 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is issued under a larger indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the provision of Vyvanse 30 mg capsules in 100-count bottles. The total potential value of the delivery order is $3,313.61 and the performance period runs through February 27, 2024. Amerisourcebergen Drug Corp, as a for-profit organization, is the prime...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed-price delivery order contract worth $3,817.72 for 4,563,962,745 units of the pharmaceutical product Vyvanse 10 mg capsules. The contract has a period of performance through March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is likely part of a larger indefinite delivery...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FNCZ3Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of Vyvanse 10 mg capsules in 100-count packages, with a ceiling value of $4,387.92 and a performance period through April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and has no set-aside designation for this award. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to provide pharmaceutical products and medical supplies to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 4/3/24 |